GSK-3 inhibitors (DeveloGen)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameGSK-3 inhibitors (DeveloGen)
Drug Alias NamecazpaulloneKuStu-238KuStu-172KuStu-144
ClassificationSmall molecules
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryWestern Europe
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEvotec International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvotec International Gmbh
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A